Gaucher disease: FDA approves VPRIV
Links shared publicly online about this topic.
- 1,352total visits
Gaucher disease: FDA approves VPRIV
View full resource at news-medical.net
Tags: Lipid Storage Disease, Gaucher Disease, Stroke, Thrombotic Event, Disease and Condition, Drug, Children's Health, FDA
Most Recently Shared on February 27, 2010 at 4:57 am By:
Stroke News: Gaucher disease: FDA approves VPRIV: The U.S. Food and Drug Administration has approved velaglucera... http://twurl.nl/zaidct
Medical News: FDA Says No to Gaucher Drug - in Genetics, Genetics from MedPage Today
medpagetoday.com — “The FDA declined to approve a new replacement therapy for Gaucher disease, citing inadequate data on the drug's clinical performance and manufacturing controls, according to its manufacturer.” View full resource at medpagetoday.com
Most Recently Shared on February 25, 2011 at 6:11 pm By:
FDA Says No to Gaucher Drug http://bit.ly/eBCYzR
U.S. seeks more data on Protalix drug; shares sink | Reuters
reuters.com — “WASHINGTON (Reuters) - Health regulators want more data on Protalix Biotherapeutics Inc and Pfizer Inc's experimental drug for Gaucher disease before deciding whether to approve the therapy for patients” View full resource at reuters.com
Most Recently Shared on February 25, 2011 at 2:00 pm By:
FDA wants more data on Pfizer-Protalix drug: CHICAGO (Reuters) - U.S. health regulators have asked... http://bit.ly/ij4khQ #health #news
VPRIV® (velaglucerase Alfa) Approved In Canada For The Treatment Of Type I Gaucher Disease
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that Health Canada has approved VPRIV (velaglucerase alfa), an enzyme replacement therapy (ERT) for l” View full resource at medicalnewstoday.com
Most Recently Shared on December 4, 2010 at 2:41 pm By:
VPRIV® (velaglucerase Alfa) Approved In Canada For The Treatment Of Type I Gaucher Disease… http://goo.gl/fb/BpI84
Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VPRIV (velaglucerase alfa), an enzyme replacement therapy (ERT) for long-term use in pediatric and adult type 1 Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on December 1, 2010 at 12:14 pm By:
Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease: Shire plc, the global specia... http://bit.ly/eXIaXq
Shire receives approval for VPRIV to treat type 1 Gaucher disease
news-medical.net — “Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on August 27, 2010 at 10:15 am By:
Shire receives approval for VPRIV to treat type 1 Gaucher disease: Shire, the global specialty biopharmaceutical c... http://bit.ly/d0YvUf
Shire Announces FDA Approval Of VPRIV(TM) (velaglucerase Alfa For Injection) For The Treatment Of Type 1 Gaucher Disease
medicalnewstoday.com — “Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human ce” View full resource at medicalnewstoday.com
Most Recently Shared on May 29, 2010 at 1:06 pm By:
Shire Announces FDA Approval Of VPRIV(TM) (velaglucerase Alfa For Injection) For The Treatment Of Type 1 Gaucher Disease http://mnt.to/3Dhn
Vpriv available for Type 1 Gaucher disease - ONA
oncologynurseadvisor.com — “Shire announced that Vpriv (velaglucerase alfa for injection) has been FDA approved and made available for the treatment of Type 1 Gaucher disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 1, 2010 at 4:13 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Vpriv available for Type 1 Gaucher disease http://goo.gl/fb/3kQb
FDA Approves VPRIV to Treat Gaucher Disease
drugs.com — “VPRIV (velaglucerase alfa) is used to treat Gaucher disease. Includes VPRIV side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 5:02 am By:
FDA Approves VPRIV to Treat Gaucher Disease - http://bit.ly/dATgn7
Replacement Therapy Approved for Gaucher Disease - Drugs.com MedNews
drugs.com — “Velaglucerase alfa for injection (VPRIV) has been approved by the U.S. Food and Drug Administration to treat a rare inherited disorder called Gaucher disease, t” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 4:29 am By:
Replacement Therapy Approved for Gaucher Disease - http://bit.ly/9m1onF
Medical News: New Drug for Genetic Disorder Gets Final FDA Nod - in Product Alert, Devices and Vaccines from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has formally approved the enzyme replacement therapy velaglucerase alfa (VPRIV) -- already okayed for pre-approval marketing -- for pediatric and adult patients with Gaucher dise” View full resource at medpagetoday.com
Most Recently Shared on February 27, 2010 at 10:07 pm By:
New Drug for Genetic Disorder Gets Final FDA Nod WASHINGTON (MedPage Today) -- The FDA has formally approved the enzy.. http://bit.ly/axEHSd
FDA Approves Therapy To Treat Gaucher Disease
tweetmeme.com — “The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease. Gaucher disease occurs in people who do not produce enough of an enzy” View full resource at tweetmeme.com
Most Recently Shared on February 27, 2010 at 2:49 pm By:
Healthcare TweetMeme Health Social Media
FDA Approves Therapy To Treat Gaucher Disease http://retwt.me/1MjGN (via @healthytweet)
FDA formally approves new drug for Gaucher disease | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The Food and Drug Administration on Friday formally approved a new drug called velaglucerase alfa for injection (tradenamed VPRIV) for treatment of the rare genetic disorder Gaucher disease. The agency has already been allowing the company to ship the drug...” View full resource at latimesblogs.latimes.com
Most Recently Shared on February 26, 2010 at 11:27 pm By:
LA Times Health News Health News
FDA formally approves new drug for Gaucher disease http://bit.ly/9Dy9gD
2d Cerezyme rival available in trials - The Boston Globe
boston.com — “For the second time in two weeks, federal regulators have moved to counter the ongoing supply shortage of Cerezyme, Genzyme Corp.’s treatment for Gaucher disease, by letting doctors prescribe a rival drug before it has won approval for commercial use.” View full resource at boston.com
Most Recently Shared on August 18, 2009 at 1:34 pm By:
Twice in 2 weeks, FDA allows docs to prescribe unapproved Gaucher's drug to make up for shortage of market-leading drug http://tr.im/wBJE
Advertisement
